Complera challenges HIV market again with health insurance benefits

Published: 2017-10-11 14:50:05

Updated: 2017-10-11 14:50:10

Janssen Korea’s HIV treatment ‘Complera’ attracted the industry as returning the market with health insurance benefits.

The Ministry of Health and Welfare(MOHW) revised and announced health insurance registration of Complera Tab(emtricitabine, rilpivirine, tenofovir disoproxil fumarate) on the 25^th. Thus, Complera has been applied to the health insurance service since 1 October.

Complera, whi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.